Sharepoint Solutions
PRODUCTS
-
The MBX32CTR is a complete solution for mmWave and sub-THz OTA measurement with a quiet zone of 150mm that includes a full benchtop anechoic chamber, a 3D positioner, and a pair of STO-series frequency extenders.
-
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
We have centralized RNA, cell, protein, and vector engineering to improve productivity and scalability and to ensure external partners and internal programs have access to the necessary tools to build novel therapies.
-
Delve into the details of this full-service global product development and strategic regulatory group that has a proven track record of successful FDA meetings and approvals.
-
Feeling overwhelmed with the new revisions and need guidance on where to start?
WHITE PAPERS AND CASE STUDIES
-
Accelerating SARS-CoV-2 Immunotherapy Speed To Clinic
A clinical-stage biotherapeutics company developing a COVID-19 immunotherapy searched for a solution to the difficulties it faced in scaling up its manufacturing operations due to limited resources.
-
Reducing Risk And Timelines In Cell Line Development
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
A Comprehensive Planning Approach For Cancer Antibody
Discover how a clinical-stage biotech company was able to accelerate pathways for development and regulatory review of their first Phase 1 protocol for an immuno-oncology antibody.
-
Solving The Silicone Challenge In Pre-Fillable Syringes
Discover a technology platform that is revolutionizing the pre-fillable syringe market by solving the challenge of silicone sensitivity, ensuring stability for sensitive drugs.
-
A Digital Solution Embeds Quality Into Cellular Therapeutics Production
Discover how Dendreon cut review and release time by nearly 50% while maintaining a 99% right-first-time rate, which boosts collaboration, visibility, and operational efficiency across teams.
-
On-Demand Payment Technology Offers Accuracy, Speed, & Transparency
Review current grant payment practices and how new software tools can transform the process, efficiently solving the problem that first gave rise to sponsor-funded escrow accounts.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
Advancing In Silico Predictions In Early Drug Discovery
Examine a high-throughput approach that streamlines LogD measurements, offering faster and more accurate insight into compound lipophilicity to support better decision-making in early drug discovery.
-
How To Facilitate Good Clinical Data Review In Your Clinical Trial
Learn how to create a system based on connectivity and automation, aggregated and usable data, flexible analysis, and methods of collaborative data review by centralizing analysis and communications.
-
Unveiling The Critical Role of Sleep In Clinical Studies
Explore the critical role of sleep in clinical trials and its impact on health outcomes, emphasizing the need to address sleep disturbances for more effective and reliable research.
-
Response To FDA Black Box Warning
The FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies. Review the key points of this announcement concerning the CGT research community.
-
Case Study: Recruiting Pediatric Ultra-Rare Disease Patients
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
NEWS
-
Biofrontera Inc. Announces FDA Filing Of Supplemental New Drug Application For Ameluz To Permit Up To Three Tubes Per Use2/5/2024
Biofrontera Inc. ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today announced that the U.S. Food and Drug Administration (FDA) has issued a "no filing review issues identified" letter regarding the sNDA (supplementary New Drug Application) submitted by its licensor Biofrontera Bioscience GmbH to increase the maximally approved dosage from one to three tubes of Ameluz per treatment.
-
Biden-Harris Administration Announces $16.5M For US Virgin Islands Water Infrastructure Upgrades As Part Of President Biden's Investing In America Agenda2/20/2024
Today, the US Environmental Protection Agency (EPA) announced over $16.5M from President Biden's Investing in America agenda for US Virgin Islands drinking water and clean water infrastructure upgrades.
-
EPA Announces $5.8 Billion For Drinking Water, Wastewater And Stormwater Infrastructure Upgrades2/20/2024
As part of the fourth Investing in America tour, Vice President Kamala Harris and U.S. Environmental Protection Agency Administrator Michael S. Regan announced over $5.8B from President Biden’s Investing in America agenda for states, Tribes, and territories to invest in drinking water and clean water infrastructure upgrades.
-
WRF Seeks Pre-proposals For High-Priority Utility Research2/15/2024
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program. The Tailored Collaboration Program provides an opportunity for WRF subscribers to partner with WRF on projects that address issues of interest to a significant subgroup of subscribers.
-
New Study Highlights Rewilding's Role In Tackling Flood And Drought Challenges2/26/2024
Rewilding is the large-scale restoration of ecosystems to the point where nature is allowed to take care of itself.